What does LINEA TROVATA BIOCONSTRUCT do?

LINEA TROVATA BIOCONSTRUCT is a construction company in Lokeren. Public Limited, started on 26 October 2010, 1 establishment.

What is the address of LINEA TROVATA BIOCONSTRUCT?

The registered office of LINEA TROVATA BIOCONSTRUCT is located at Mosten 14-14A, 9160 Lokeren.

Is LINEA TROVATA BIOCONSTRUCT still active?

Yes. According to the CBE (29 October 2026) LINEA TROVATA BIOCONSTRUCT is active, legal situation “Normale toestand”, started on 26 October 2010.

Is LINEA TROVATA BIOCONSTRUCT registered on Peppol?

Yes, LINEA TROVATA BIOCONSTRUCT is registered on the Peppol network with ID 0208:0830628123.

What is the enterprise number of LINEA TROVATA BIOCONSTRUCT?

The enterprise number of LINEA TROVATA BIOCONSTRUCT is BE0830628123.

When was LINEA TROVATA BIOCONSTRUCT founded?

LINEA TROVATA BIOCONSTRUCT was founded on 26 October 2010.

Who are the directors of LINEA TROVATA BIOCONSTRUCT?

According to the 2025 annual accounts, the directors of LINEA TROVATA BIOCONSTRUCT are: Fleur d'or, Linea Trovata Suntec NV, OGF bvba.

Is LINEA TROVATA BIOCONSTRUCT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 October 2010; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did LINEA TROVATA BIOCONSTRUCT make in 2025?

LINEA TROVATA BIOCONSTRUCT recorded a loss after taxes of € 14,867 in financial year 2025.

What is the revenue of LINEA TROVATA BIOCONSTRUCT?

As a small company, LINEA TROVATA BIOCONSTRUCT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 3,748.

LINEA TROVATA BIOCONSTRUCT (Public Limited) - Lokeren

Dossier LINEA TROVATA BIOCONSTRUCT, printed on 29 October 2026 from databakkes.be/en/0830628123/linea-trovata-bioconstruct. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

LINEA TROVATA BIOCONSTRUCT from Lokeren, company number BE0830628123, closed financial year 2025 with a result of € -14,867 after tax. For that financial year LINEA TROVATA BIOCONSTRUCT recorded a gross margin of € 3,748 and equity of € 78,470. Compared with financial year 2024, the result moved from € -13,541 to € -14,867. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 78,470

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -14,867

▼ 10 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,103

▲ € 11,838 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -227,030.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 30,708 Revenue 2022: € 30,708 First fiscal year in the series	€ 29,374 Revenue 2023: € 29,374 ▼ 4% vs 2022 (€ 30,708) Unfavourable step	€ 56,051 Revenue 2024: € 56,051 ▲ 91% vs 2023 (€ 29,374) Favourable step	-
Gross margin	€ 15,648 Gross margin 2022: € 15,648 First fiscal year in the series	€ 15,054 Gross margin 2023: € 15,054 ▼ 4% vs 2022 (€ 15,648) Unfavourable step	€ 43,844 Gross margin 2024: € 43,844 ▲ 191% vs 2023 (€ 15,054) Favourable step	€ 3,748 Gross margin 2025: € 3,748 ▼ 91% vs 2024 (€ 43,844) Unfavourable step	▼ 91%
Profit after taxes	€ 14,136 Profit after taxes 2022: € 14,136 First fiscal year in the series	€ 13,109 Profit after taxes 2023: € 13,109 ▼ 7% vs 2022 (€ 14,136) Unfavourable step	€ -13,541 Profit after taxes 2024: € -13,541 ▼ € 26,650 vs 2023 (€ 13,109) Unfavourable step	€ -14,867 Profit after taxes 2025: € -14,867 ▼ € 1,325 vs 2024 (€ -13,541) Unfavourable step	▼ € 1,325
Equity	€ 93,768 Equity 2022: € 93,768 First fiscal year in the series	€ 106,877 Equity 2023: € 106,877 ▲ 14% vs 2022 (€ 93,768) Favourable step	€ 93,336 Equity 2024: € 93,336 ▼ 13% vs 2023 (€ 106,877) Unfavourable step	€ 78,470 Equity 2025: € 78,470 ▼ 16% vs 2024 (€ 93,336) Unfavourable step	▼ 16%
Total debts	€ 222 Total debts 2022: € 222 First fiscal year in the series	€ 4,015 Total debts 2023: € 4,015 ▲ € 3,793 vs 2022 (€ 222) Unfavourable step	€ 461,183 Total debts 2024: € 461,183 ▲ € 457,168 vs 2023 (€ 4,015) Unfavourable step	€ 465,317 Total debts 2025: € 465,317 ▲ 1% vs 2024 (€ 461,183) Unfavourable step	▲ 1%
Cash	€ 62,513 Cash 2022: € 62,513 First fiscal year in the series	€ 41,824 Cash 2023: € 41,824 ▼ 33% vs 2022 (€ 62,513) Unfavourable step	€ 265 Cash 2024: € 265 ▼ 99% vs 2023 (€ 41,824) Unfavourable step	€ 12,103 Cash 2025: € 12,103 ▲ € 11,838 vs 2024 (€ 265) Favourable step	▲ € 11,838
Land & buildings	-	-	€ 541,970 Land & buildings 2024: € 541,970 First fiscal year in the series	€ 531,427 Land & buildings 2025: € 531,427 ▼ 2% vs 2024 (€ 541,970) Unchanged	▼ 2%
Retained profit	€ -211,732 Retained profit 2022: € -211,732 First fiscal year in the series	€ -198,623 Retained profit 2023: € -198,623 ▲ € 13,109 vs 2022 (€ -211,732) Favourable step	€ -212,164 Retained profit 2024: € -212,164 ▼ € 13,541 vs 2023 (€ -198,623) Unfavourable step	€ -227,030 Retained profit 2025: € -227,030 ▼ € 14,867 vs 2024 (€ -212,164) Unfavourable step	▼ € 14,867
Balance sheet total	€ 93,990 Balance sheet total 2022: € 93,990 First fiscal year in the series	€ 110,892 Balance sheet total 2023: € 110,892 ▲ 18% vs 2022 (€ 93,990) Unchanged	€ 554,519 Balance sheet total 2024: € 554,519 ▲ € 443,627 vs 2023 (€ 110,892) Unchanged	€ 543,786 Balance sheet total 2025: € 543,786 ▼ 2% vs 2024 (€ 554,519) Unchanged	▼ 2%

Key figures of LINEA TROVATA BIOCONSTRUCT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LINEA TROVATA BIOCONSTRUCT?

What happened at LINEA TROVATA BIOCONSTRUCT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Fleur d'or stepped down as director. NBB
2029 Linea Trovata Suntec NV stepped down as director. NBB
2029 OGF bvba stepped down as director. NBB
Aug 31, 2026 New annual accounts for financial year 2025: loss of € 14,867. filed late Source: NBB ↗
2023 Fleur d'or became a director. NBB
2023 Linea Trovata Suntec NV became a director. NBB
2023 OGF bvba became a director. NBB
Oct 26, 2010 New establishment in Lokeren. KBO

In short

From € 14,136 profit in 2022 to € 14,867 loss in 2025.

Best year ever: 2022, with € 14,136 profit.

Original PDFs at the National Bank ↗

Management

LINEA TROVATA SUNTEC 98%

The stake of LINEA TROVATA SUNTEC comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

LINEA TROVATA BIOCONSTRUCT

The shares are held by LINEA TROVATA SUNTEC (98%).

Directors

According to the 2025 annual accounts

Fleur d'or

Director

Also active at: BIOSFEER LT, LINEA TROVATA SUNTEC

since 2023 · until 2029

Linea Trovata Suntec NV

Director · represented by Piet Van Poucke

Also active at: BIOSFEER LT, LINEA TROVATA WARMTETECHNIEK

since 2023 · until 2029

OGF bvba

Director · represented by Otto Garritsen

Owns 8.1% via LINEA TROVATA SUNTEC

Also active at: Building Solar Invest, BIOSFEER LT, LINEA TROVATA SUNTEC, ECHOMEDIC

since 2023 · until 2029

Shareholders

LINEA TROVATA SUNTEC · holding of OGF bvba

98%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Mosten 14-14A

9160 Lokeren

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Building Solar Invest same network

€ 322,666 gross margin · 2025

AESCO

€ 26,507 gross margin · 2025

BIOSFEER LT same network

€ 40,500 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0830.628.123

VAT number

BE 0830.628.123

Registered office

Mosten 14-14A, 9160 Lokeren

Names & denominations

LINEA TROVATA BIOCONSTRUCT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

26 October 2010

Peppol

Active · Active since 1 Jan 2001

Contact

[email protected]

Activities · NACE

Algemene bouw van residentiële gebouwen

Algemene bouw van kantoorgebouwen

Algemene bouw van andere niet-residentiële gebouwen

View on CBE Public ↗ Annual accounts (NBB) ↗

LINEA TROVATA BIOCONSTRUCT

Warning lights

Financials

What happened to LINEA TROVATA BIOCONSTRUCT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions